Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameTelix Pharmaceuticals Limited
-
Registration countryAustralia
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









